Axonics Modulation Technologies Inc (AXNX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Axonics Modulation Technologies Inc (AXNX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10499
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axonics Modulation Technologies Inc (Axonics) is an independent medical device company that develops and commercializes implantable neuromodulation technology for the treatment of urinary and bowel dysfunction. The company’s Sacral Neuromodulation System (r-SNM) is designed for the treatment of overactive bladder, fecal incontinence, and urinary retention. The Axonics r-SNM system comprises a temporary disposable external trial system and implantable components such as a miniaturized rechargeable implantable stimulator, a universal remote control and an intuitive clinician programmer which facilitates the lead placement procedure and programming, tined lead, and patient-friendly items including charging system optimized for reduced charge time with no heating. Axonics is headquartered in Irvine, California, the US.

Axonics Modulation Technologies Inc (AXNX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Axonics Modulation Technologies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10
Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11
Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13
Axonics Modulation Raises USD17.3 Million in Venture Financing 15
Axonics Modulation Technologies Raises US$32.6 Million In Series A Financing 16
Private Equity 18
Axonics Modulation Raises USD20.1 Million in Equity Financing 18
Axonics Modulation Technologies Inc – Key Competitors 19
Axonics Modulation Technologies Inc – Key Employees 20
Axonics Modulation Technologies Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 06, 2017: Axonics Appoints Dr. Karen L. Noblett as Chief Medical Officer 22
Product News 23
Nov 15, 2018: Axonics granted Seven U.S. Utility Patents related to its Implantable Sacral Neuromodulation technology 23
Dec 04, 2017: Axonics Granted Seven New U.S. Patents Related to Its Implantable Sacral Neuromodulation Technology 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Axonics Modulation Technologies Inc, Medical Equipment, Key Facts 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axonics Modulation Technologies Inc, Deals By Market, 2012 to YTD 2018 8
Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10
Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11
Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13
Axonics Modulation Raises USD17.3 Million in Venture Financing 15
Axonics Modulation Technologies Raises US$32.6 Million In Series A Financing 16
Axonics Modulation Raises USD20.1 Million in Equity Financing 18
Axonics Modulation Technologies Inc, Key Competitors 19
Axonics Modulation Technologies Inc, Key Employees 20

List of Figures
Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axonics Modulation Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Axonics Modulation Technologies Inc (AXNX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sparton Corporation:企業の戦略・SWOT・財務情報
    Sparton Corporation - Strategy, SWOT and Corporate Finance Report Summary Sparton Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Texas Instruments Incorporated (TXN):電力:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Banco Davivienda Sa
    Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report Summary Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lario Oil & Gas Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Co (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and explo …
  • Sinolink Worldwide Holdings Ltd:企業の戦略・SWOT・財務情報
    Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …
  • JSS Medical Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JSS Medical Research Inc (JSS Medical Research) is a contract research organization that offers clinical research services. The organization provides clinical trial services in therapeutic areas such as oncology, infectious disease, cardiovascular disorders, psychiatry, neurology, respirator …
  • Borregaard ASA (BRG):企業の財務・戦略的SWOT分析
    Borregaard ASA (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enzo Biochem Inc (ENZ):企業の製品パイプライン分析
    Summary Enzo Biochem Inc (Enzo Biochem) is a life sciences and biotechnology company with a focus on harnessing genetic processes for the development of research tools, therapeutics and diagnostics. It also provides reference laboratory services to the medical community. The company focuses on the d …
  • Microbot Medical Inc (MBOT):企業の財務・戦略的SWOT分析
    Summary Microbot Medical Inc (Microbot), formerly StemCells Inc, is a pre-clinical medical device company that researches, designs and develops micro-robotics assisted medical technologies for minimally invasive surgeries. The company’s product candidates comprises Self Cleaning Shunt, intended for …
  • Harbin Bank Co Ltd:企業の戦略・SWOT・財務分析
    Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • D.R. Horton, Inc.:企業の戦略・SWOT・財務情報
    D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ConSynance Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics), formerly Concerted Therapeutics Inc is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company provides pipeline programs such as CSTI-100, CSTI-200, and CSTI-300, a …
  • The Hartford Financial Services Group, Inc.:戦略・SWOT・企業財務分析
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • BTA Bank JSC:企業の戦略・SWOT・財務情報
    BTA Bank JSC - Strategy, SWOT and Corporate Finance Report Summary BTA Bank JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Agappe Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Agappe Diagnostics Ltd (Agappe) is an in vitro diagnostic company that manufactures clinical chemistry and immuno turbidimetry products. The company’s products categories include biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; poin …
  • Home Capital Group Inc.:企業の戦略・SWOT・財務分析
    Home Capital Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Home Capital Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank Of Ireland (Uk) Plc
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kopran Ltd (KOPRAN):企業の財務・戦略的SWOT分析
    Summary Kopran Ltd (Kopran) is a pharmaceutical company that manufactures finished dosage forms and active pharmaceutical ingredients. The company’s finished dosage form includes tablets, dry powders for oral suspension, capsules, injections and syrups. It offers products in the therapeutic areas of …
  • First Solar, Inc.:企業の戦略・SWOT・財務情報
    First Solar, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Solar, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆